DDDina Daaboul

Dina Daaboul

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Dina Daaboul has a total of 39 co-authors. Here are the top co-authors by number of shared publications:

  • Thierry Naas

    Team ‘Resist’, UMR1184 ‘Infectious Disease Models and Innovative Therapies (IDMIT)’ (INSERM, University Paris-Saclay, CEA), Faculty of Medicine, University Paris-Saclay, 94270 Le Kremlin-Bicêtre, France

    6 shared publications
  • Marwan Osman

    Department of Neurosurgery, Yale University School of Medicine

    5 shared publications
  • Issmat I. Kassem

    Center for Food Safety, Department of Food Science and Technology, University of Georgia, 1109 Experiment Street, Griffin, GA 30223-1797, USA

    3 shared publications
  • Khaled El Omari

    Laboratoire Microbiologie Santé et Environnement (LMSE), Doctoral School of Sciences and Technology, Faculty of Public Health, Lebanese University, Tripoli 1300, Lebanon; Quality Control Center Laboratories at the Chamber of Commerce, Industry & Agriculture of Tripoli & North Lebanon, Tripoli 1300, Lebanon

    3 shared publications
  • Saoussen Oueslati

    Team ‘Resist’, UMR1184 ‘Infectious disease models and innovative therapies (IDMIT)’ INSERM, Université Paris-Saclay, CEA, Health, Faculty of Medicine, Le Kremlin-Bicêtre, France

    3 shared publications
  • Anahita Ghorbani Tajani

    Department of Animal Science, University of Wyoming, Laramie, WY 82071, USA

    2 shared publications

Latest Publications

  • Open Access

    The Emergence and Dissemination of the Mobile Colistin Resistance (mcr) Genes in Humans, Animals, and Environments Across the Middle East and North Africa (MENA) Region

    by Jouman W. Hassan, Souad Fayad, Nahla Eltai, Dina Daaboul, Marwan Osman, Thierry Naas, Issmat I. Kassem

    Colistin, a last-resort antibiotic, has been used in human medicine for treating infections with recalcitrant multidrug-resistant Gram-negative bacteria. However, the unregulated use of colistin in agricultural and clinical settings has accelerated the emergence and global spread of the mobile colistin resistance (mcr) genes. While mcr genes have been reported in different matrices globally, data from the Middle East and North Africa (MENA) region remain limited or absent for many countries. This knowledge gap is problematic, because conflict, overcrowding, weak regulatory frameworks, and hosting some of the world’s largest multicultural religious gatherings might collectively create conditions that amplify and spread mcr across the MENA region and beyond. Several countries in the MENA region, particularly Egypt, Lebanon, Algeria, and Tunisia, have reported different mcr genes across multiple matrices. Many mcr-positive isolates were also resistant to multiple other antibiotics and co-carried additional antibiotic resistance genes (ARGs), including those encoding extended-spectrum β-lactamases and carbapenemases. Moreover, mcr has been detected in different bacterial hosts with diverse sequence types and on various plasmid backbones. In this narrative review, we comprehensively compiled, summarized, and analyzed all available reports on mcr in the MENA region, focusing on major online search engines and databases. Our objectives were (i) map the molecular epidemiology of mcr, (ii) highlight the need for better antimicrobial stewardship programs, and (iii) emphasize the importance of implementing integrated national and regional One Health action plans. We also discuss the need for robust surveillance efforts that extend beyond clinical settings to better understand and mitigate the spread of mcr.

  • Caractérisation moléculaire des Entérobactéries productrices de bêta-lactamases à spectre étendu et de carbapénèmases isolées des 3 compartiments (Humain, animaux et environnement) dans une approche ‘’One Health’’

    by Dina Daaboul

    La résistance aux antibiotiques (AMR) et plus particulièrement les Entérobactéries productrices de carbapénèmases (EPC) ne cessant d'augmenter à l'échelle planétaire, constitue une menace pour la santé publique mondiale avec des infections bactériennes qui sont de plus en plus difficiles à traiter. Les EPCs, identifiées dans tous les compartiments, humains, animaux et environnementaux, nécessitent une approche globale dite ‘One health' pour pouvoir les combattre efficacement. Le Liban, pays à faible revenus et devant faire face à sa pire crise économique impactant sérieusement son système de santé, doit également prendre en charge de nombreux réfugiés venant des pays voisins. Ainsi les données épidémiologiques et moléculaires de la résistance aux antibiotiques au Liban chez l'homme, les animaux et dans le secteur alimentaire ne sont que parcellaires. L'objectif de cette thèse est de mieux comprendre l'épidémiologie des EPC et les voies de disséminations des bactéries et des gènes de résistance entre les différents compartiments au Liban. Une première étude, menées sur des isolats cliniques a révélé une dissémination principalement de E. coli résistantes aux carbapénèmes, suggérant une dissémination communautaire importante. Les carbapénèmases identifiées appartenaient majoritairement à la classe B et D et une prévalence élevée des souches d'E.coli productrice de blaNDM-5 a été signalée. De même, une localisation plasmidique de 2 metallo b- lactamases chez une même souche d'Enterobacter a été mise en évidence. Ensuite une deuxième étude a été menée au sein des camps des réfugiés syriens afin d'étudier la prévalence des gènes de résistance et la structure de la population des isolats résistants aux carbapénèmes chez cette population. Les résultats de cette étude signalent une situation alarmante au sein des camps des réfugiés syriens où nous avons détecté des souches multirésistantes au sein des camps (réfugiés et leur environnement ainsi que chez les animaux élevés dans les camps) et dans une rivière au bord de ces camps. De plus, nous avons mené une troisième étude sur des isolats vétérinaires pour explorer la présence et le portage des déterminants de la résistance aux antibiotiques. Ainsi, nous avons décrit pour la première fois la présence du gène blaNDM-5 chez les animaux de compagnon. Nos résultats ont révélé une dissémination des gènes de résistances aux carbapénèmes chez les entérobactéries isolées à l'hopital mais aussi chez les animaux, suggérant que ces derniers puissent être des réservoirs de bactéries multirésistantes. Ces résultats sont alarmants et soulignent la nécessité urgente de réévaluer la gestion efficace des antimicrobiens afin de limiter l'émergence de la résistance aux antibiotiques au Liban.

  • Open Access

    Genomic characterization of plasmid-borne colistin resistance variants, mcr-1.1 and mcr-1.26, in multidrug-resistant Escherichia coli isolated from backyard farm animals

    by Dina Daaboul, Issmat I. Kassem, Khaled El Omari, Nahla O. Eltai, Jouman Hassan, Hadi Al Jamal, Souad Fayad, Rayane Salma, Anahita Ghorbani Tajani, Bledar Bisha, et al.


  • Open Access

    Antibiotic Susceptibility Profiles of Bacterial Isolates Recovered from Abscesses in Cattle and Sheep at a Slaughterhouse in Algeria

    by Chahrazed Yousfi, Saoussen Oueslati, Dina Daaboul, Delphine Girlich, Alexis Proust, Chafia Bentchouala, Thierry Naas

    Abscesses represent the most prominent emerging problem in the red meat industry, leading to great economic constraints and public health hazards. Data on etiological agents present in these purulent lesions in Algeria are very scarce. The aim of this study was to identify the bacteria responsible for these abscesses and to determine their antibiotic susceptibility profiles. A total of 123 samples of abscesses from 100 slaughtered sheep and 23 slaughtered cattle were cultured in several media. A total of 114 bacterial isolates were cultured from 103 abscesses. Bacteria were identified using MALDI–TOF, and antibiotic susceptibility was determined by the disk diffusion method on Mueller–Hinton agar. A total of 73.6% (n = 84) corresponded to Enterobacterales, of which four were multidrug-resistant (MDR). These isolates, together with Staphylococcus aureus, coagulase negative Staphylococci, and seven randomly chosen susceptible Escherichia coli isolates, were further characterized using WGS. Resistome analysis of the four MDR Enterobacterales isolates revealed the presence of OXA-48 carbapenemase in two Klebsiella pneumoniae ST985 and one E. coli ST10 isolates and a CTX-M-15 ESBL in one E. coli isolate ST1706. Two coagulase-negative Staphylococci isolates were found to carry the mecA gene. WGS showed the presence of different resistance genes and virulence genes. Our study revealed 5% of MDR Enterobacterales (including ESBLs and carbapenemases) identified from abscesses, thus urging the need for abscess monitoring in slaughterhouses.


  • Open Access

    Multidrug-resistant pathogens contaminate river water used in irrigation in disenfranchised communities

    by Marwan Osman, Dina Daaboul, Anahita Ghorbani Tajani, Khaled El Omari, Bledar Bisha, Jouman Hassan, Casey L. Cazer, Kathryn J. Fiorella, Nabil Karah, Aula Abbara, et al.


  • Open Access

    The occurrence of the carbapenemase gene, blaNDM-5, on a transmissible IncX3 plasmid in multidrug-resistant Escherichia coli isolated from a farm dog

    by Dina Daaboul, Issmat I. Kassem, Khaled El Omari, Fouad Dabboussi, Saoussen Oueslati, Thierry Naas, Marwan Osman


  • Open Access

    Prevalence and Molecular Mechanisms of Carbapenem Resistance among Gram-Negative Bacilli in Three Hospitals of Northern Lebanon

    by Mariam Rima, Saoussen Oueslati, Laura Dabos, Dina Daaboul, Hassan Mallat, Elie Bou Raad, Marcel Achkar, Osman Mawlawi, Sandrine Bernabeu, Rémy A. Bonnin, et al.

    Carbapenem resistance (CR) is an emerging health issue. Epidemiological surveys on carbapenem-resistant Gram-negative bacilli (CR-GNB) in Lebanon remain scarce. In this study, we determined the prevalence of CR-GNB isolated between 2015 to 2019 in three hospitals in northern Lebanon: 311 CR-Enterobacterales (out of 11210; 2.8%), 155 CR-Pseudomonas (out of 1034; 15%) and 106 CR- Acinetobacter (out of 184; 57.6%) were identified. CR mechanisms were determined for 146 randomly chosen isolates: the Carba NP test revealed an enzymatic resistance to carbapenems in 109 isolates (out of 146, 74.7%). Produced carbapenemases were evaluated by the NG-Test Carba5, NG-Test OXA-23 immunochromatographic assays and PCR. Carbapenemase-producing (CP) Enterobacterales expressed blaOXA-48-like, blaNDM-like and blaVIM-like genes and CP-Pseudomonas expressed blaIMP-like and blaVIM-like genes, whereas CP-Acinetobacter expressed blaOXA-23-like genes. The NG-Test Carba5 results were confirmed by PCR sequencing and revealed several variants, such as NDM-19, VIM-62 and OXA-162, never described so far in Lebanon. Isolates with discordant results were sequenced by WGS and highlighted novel variants of the natural oxacillinases of Pseudomonas aeruginosa: blaOXA-50-like genes. Their role in carbapenem resistance should be further studied. Overall, our findings highlight an alarming situation and encourage health care centers to establish performant registration systems that could help in limiting resistance spread.